- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03865498
Twitter Based Social Support for Hispanic and Black Dementia Caregivers (Tweet-S2)
December 23, 2024 updated by: Sunmoo Yoon, Columbia University
Using Twitter to Enhance the Social Support of Hispanic and Black Dementia Caregivers
The prevalence of dementia is higher in Hispanics and African Americans than non-Hispanic Whites.
Moreover, dementia caregivers often experience loneliness as well decreased health status.
The expansion of social media use among Hispanics and African Americans, particularly Twitter - a short message service - offers great promise for improving social support.
This study aims to evaluate changes of discussion topics, sentiment and networking styles (i.e., number of followers) among anonymous followers of our two Twitter networks; the African American/Black dementia caregiver group and the Hispanic dementia caregiver group.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will utilize Twitter networks to post a daily message for dementia caregivers for a year, and set up a monthly group chat.
Study Type
Interventional
Enrollment (Actual)
966
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Irving Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years of age or older
- Black or Hispanic, living in the U.S. including the U.S. territories
- a dementia caregiver with any duration, able to speak English or Spanish/bilingual
- must agree to terms of conditions of use and privacy policy and rules of one of the two dementia caregiver network (Hispanic @dcnh, Black @dcnaab), the Twitter user agreement of the terms of service, Twitter privacy policy and Twitter rules including intellectual property, violence, misconduct, abuse behavior, private information and spam and security
- use a smartphone or a feature phone (i.e., a cell phone with text messaging)
Exclusion Criteria:
- do not have de-identified Twitter account, children, not a dementia family caregiver
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hispanic dementia caregivers
De-identified followers of our Hispanic dementia caregiver Twitter network will receive messages from the network (Twitter for Hispanic caregivers' intervention).
|
This group will be asked to follow and use (i.e., retweet, reply, like) our Hispanic Twitter network for social support
|
|
Experimental: African American dementia caregivers
De-identified followers of our African American dementia caregiver Twitter network will receive messages from the network (Twitter for African American caregivers' intervention).
|
This group will be asked to follow and use (i.e., retweet, reply, like) our African American Twitter network for social support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who do Not Engage in Twitter Activities
Time Frame: 12 months
|
Macro level: The number of participants who do not engage in Twitter activities (i.e., retweet, reply, like, post) within the Twitter network for dementia caregivers
|
12 months
|
|
Emotional Valence Score
Time Frame: 12 months
|
Emotional valence (macro level) detected from text data (e.g., "This is so helpful": emotion score +4; "I am sad": emotion score -6).
Emotional valence score ranges from -10 to +10; -10 indicates negative valence and +10 indicates positive valence.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Auto-detected Small Groups
Time Frame: 12 months
|
Meso level: number of small group automatically detected based on Twitter activities (i.e., retweet); for example 0 means no small-group activity detected, 7 small groups mean seven distinct cliques/grouping activities detected where the users are communicating, supporting and responding within our Twitter network.
|
12 months
|
|
Percentage of Balanced Triads
Time Frame: 12 months
|
Micro level: % balanced communication triad, 2 or 3 people responding and communicating with equal or similar frequency; 0 reflects non-optimal communication indicating domination, avoidance or ignorance.
8 means there are 8% triads who maintain healthy communication.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sunmoo Yoon, PhD, Associate Research Scientist in the Department of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 12, 2022
Primary Completion (Actual)
October 31, 2023
Study Completion (Actual)
November 20, 2023
Study Registration Dates
First Submitted
March 4, 2019
First Submitted That Met QC Criteria
March 5, 2019
First Posted (Actual)
March 7, 2019
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 23, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAS3305
- R01AG060929-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.